To identify the genes that confer resistance to MEK inhibition, they found that the ERN1-JNK-Jun pathway is a novel regulator of KRAS-mutated colon cancer response to MEK inhibitors, providing a new treatment option for colon cancer resistance to MEK inhibitors (109). Here, MAPK8 is linked to colonic neoplasm.